Stone RM - Search Results

1

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia.

Stein EM, DiNardo CD, Pollyea DA, Fathi AT, Roboz GJ, Altman JK, Stone RM, DeAngelo DJ, Levine RL, Flinn IW, Kantarjian HM, Collins R, Patel MR, Frankel AE, Stein A, Sekeres MA, Swords RT, Medeiros BC, Willekens C, Vyas P, Tosolini A, Xu Q, Knight RD, Yen KE, Agresta S, de Botton S, Tallman MS. Stein EM, et al. Among authors: stone rm. Blood. 2017 Aug 10;130(6):722-731. doi: 10.1182/blood-2017-04-779405. Epub 2017 Jun 6. Blood. 2017. PMID: 28588020 Free PMC article. Clinical Trial.

2

Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiation-inducing agent.

Andreeff M, Stone R, Michaeli J, Young CW, Tong WP, Sogoloff H, Ervin T, Kufe D, Rifkind RA, Marks PA. Andreeff M, et al. Blood. 1992 Nov 15;80(10):2604-9. Blood. 1992. PMID: 1421378 Free article. Clinical Trial.

3

Inhibition of phorbol ester-induced monocytic differentiation and c-fms gene expression by dexamethasone: potential involvement of arachidonic acid metabolites.

Stone RM, Imamura K, Datta R, Sherman ML, Kufe DW. Stone RM, et al. Blood. 1990 Sep 15;76(6):1225-32. Blood. 1990. PMID: 2144778 Free article.

4

Phospholipase C activates protein kinase C and induces monocytic differentiation of HL-60 cells.

Stone RM, Weber BL, Spriggs DR, Kufe DW. Stone RM, et al. Blood. 1988 Aug;72(2):739-44. Blood. 1988. PMID: 3165300 Free article.

5

Complete remission in acute promyelocytic leukemia despite persistence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patients.

Stone RM, Maguire M, Goldberg MA, Antin JH, Rosenthal DS, Mayer RJ. Stone RM, et al. Blood. 1988 Mar;71(3):690-6. Blood. 1988. PMID: 3422828 Free article.

6

A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity.

Inhorn RC, Aster JC, Roach SA, Slapak CA, Soiffer R, Tantravahi R, Stone RM. Inhorn RC, et al. Among authors: stone rm. Blood. 1995 Apr 1;85(7):1881-7. Blood. 1995. PMID: 7661940 Free article. Review.

7

The approach to the elderly patient with acute myeloid leukemia.

Stone RM, Mayer RJ. Stone RM, et al. Hematol Oncol Clin North Am. 1993 Feb;7(1):65-79. Hematol Oncol Clin North Am. 1993. PMID: 7680642 Review.

8

A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.

Larson RA, Dodge RK, Burns CP, Lee EJ, Stone RM, Schulman P, Duggan D, Davey FR, Sobol RE, Frankel SR, et al. Larson RA, et al. Among authors: stone rm. Blood. 1995 Apr 15;85(8):2025-37. Blood. 1995. PMID: 7718875 Free article. Clinical Trial.

9

All-trans retinoic acid reverses phorbol ester resistance in a human myeloid leukemia cell line.

Yang KD, Mizobuchi T, Kharbanda SM, Datta R, Huberman E, Kufe DW, Stone RM. Yang KD, et al. Among authors: stone rm. Blood. 1994 Jan 15;83(2):490-6. Blood. 1994. PMID: 8286746 Free article.

10

Treatment of the newly diagnosed adult with de novo acute myeloid leukemia.

Stone RM, Mayer RJ. Stone RM, et al. Hematol Oncol Clin North Am. 1993 Feb;7(1):47-64. Hematol Oncol Clin North Am. 1993. PMID: 8449864 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

547 results

Search Page